148 related articles for article (PubMed ID: 3542201)
41. Immunization against recombinant GnRH-I alters testicular structure in an experimental boar model.
Li Y; Liu Y; Su S; Pu Y; Zhang X; Fang F
Zygote; 2015 Feb; 23(1):125-35. PubMed ID: 23991935
[TBL] [Abstract][Full Text] [Related]
42. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.
Glode LM; Robinson J; Gould SF
Lancet; 1981 May; 1(8230):1132-4. PubMed ID: 6112490
[No Abstract] [Full Text] [Related]
43. Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat.
Kangasniemi M; Wilson G; Huhtaniemi I; Meistrich ML
Endocrinology; 1995 Aug; 136(8):3677-80. PubMed ID: 7628410
[TBL] [Abstract][Full Text] [Related]
44. Modification of cyclophosphamide-induced pulmonary toxicity in normal mice.
Allalunis-Turner MJ; Siemann DW
NCI Monogr; 1988; (6):51-3. PubMed ID: 3127733
[TBL] [Abstract][Full Text] [Related]
45. Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice.
Carmely A; Meirow D; Peretz A; Albeck M; Bartoov B; Sredni B
Hum Reprod; 2009 Jun; 24(6):1322-9. PubMed ID: 19240057
[TBL] [Abstract][Full Text] [Related]
46. Suppression of meiosis of male germ cells by an antagonist of luteinizing hormone-releasing hormone.
Szende B; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):901-3. PubMed ID: 2405399
[TBL] [Abstract][Full Text] [Related]
47. Restoration of spermatogenesis and fertility in azoospermic mutant mice by suppression and reelevation of testosterone followed by intracytoplasmic sperm injection.
Tohda A; Okuno T; Matsumiya K; Okabe M; Kishikawa H; Dohmae K; Okuyama A; Nishimune Y
Biol Reprod; 2002 Jan; 66(1):85-90. PubMed ID: 11751268
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of A spermatogonial proliferation and differentiation in irradiated rats by gonadotropin-releasing hormone antagonist administration.
Shuttlesworth GA; de Rooij DG; Huhtaniemi I; Reissmann T; Russell LD; Shetty G; Wilson G; Meistrich ML
Endocrinology; 2000 Jan; 141(1):37-49. PubMed ID: 10614621
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells.
Lu CC; Meistrich ML
Cancer Res; 1979 Sep; 39(9):3575-82. PubMed ID: 476683
[TBL] [Abstract][Full Text] [Related]
50. Testosterone inhibits spermatogonial differentiation in juvenile spermatogonial depletion mice.
Shetty G; Wilson G; Huhtaniemi I; Boettger-Tong H; Meistrich ML
Endocrinology; 2001 Jul; 142(7):2789-95. PubMed ID: 11415997
[TBL] [Abstract][Full Text] [Related]
51. Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse.
Nonomura M; Okada K; Hida S; Yoshida O
Urol Res; 1991; 19(2):135-40. PubMed ID: 1906655
[TBL] [Abstract][Full Text] [Related]
52. Gonadotropin-releasing hormone antagonist (Cetrorelix) therapy fails to protect nonhuman primates (Macaca arctoides) from radiation-induced spermatogenic failure.
Boekelheide K; Schoenfeld HA; Hall SJ; Weng CC; Shetty G; Leith J; Harper J; Sigman M; Hess DL; Meistrich ML
J Androl; 2005; 26(2):222-34. PubMed ID: 15713828
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment with gonadotropin-releasing hormone antagonist protects against chemotherapy-induced testicular damage 'in mice.
Levi M; Shalgi R; Ben-Aharon I
Ther Adv Med Oncol; 2022; 14():17588359221113274. PubMed ID: 36225594
[TBL] [Abstract][Full Text] [Related]
54. Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testes.
Ogawa T; Dobrinski I; Avarbock MR; Brinster RL
Tissue Cell; 1998 Oct; 30(5):583-8. PubMed ID: 9839481
[TBL] [Abstract][Full Text] [Related]
55. Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.
McKenzie WN; Sunderrajan EV; Kavanaugh JL; Braun S; Ansbacher L; Walker SE
Am J Pathol; 1988 Jun; 131(3):530-8. PubMed ID: 3381881
[TBL] [Abstract][Full Text] [Related]
56. Gonadal protection and fecundity rates in cyclophosphamide-treated rats.
Montz FJ; Wolff AJ; Gambone JC
Cancer Res; 1991 Apr; 51(8):2124-6. PubMed ID: 1901240
[TBL] [Abstract][Full Text] [Related]
57. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations.
Bucci LR; Meistrich ML
Mutat Res; 1987 Feb; 176(2):259-68. PubMed ID: 3807936
[TBL] [Abstract][Full Text] [Related]
58. Stimulation of spermatogonial differentiation in juvenile spermatogonial depletion (jsd) mutant mice by gonadotropin-releasing hormone antagonist treatment.
Matsumiya K; Meistrich ML; Shetty G; Dohmae K; Tohda A; Okuyama A; Nishimune Y
Endocrinology; 1999 Oct; 140(10):4912-5. PubMed ID: 10499552
[TBL] [Abstract][Full Text] [Related]
59. Morphological study of the effects of an GnRH agonist on the canine testis after 4 months of treatment and recovery.
Dubé D; Assaf A; Pelletier G; Labrie F
Acta Endocrinol (Copenh); 1987 Nov; 116(3):413-7. PubMed ID: 3318261
[TBL] [Abstract][Full Text] [Related]
60. Continuously proliferative stem germ cells partially repopulate the aged, atrophic rat testis after gonadotropin-releasing hormone agonist therapy.
Schoenfeld HA; Hall SJ; Boekelheide K
Biol Reprod; 2001 Apr; 64(4):1273-82. PubMed ID: 11259276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
